InnoCare Pharma Limited reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 165.82 million compared to CNY 189.39 million a year ago. Revenue was CNY 165.82 million compared to CNY 189.39 million a year ago.

Net loss was CNY 142.4 million compared to CNY 12.41 million a year ago. Basic loss per share from continuing operations was CNY 0.08 compared to CNY 0.01 a year ago. Diluted loss per share from continuing operations was CNY 0.08 compared to CNY 0.01 a year ago.